Feasibility of Using the CGM During TOC From in Persons With T2D Using Insulin

Northwell Health logo

Northwell Health

Status

Completed

Conditions

Diabetes
Type 2 Diabetes

Treatments

Device: FreeStyle Libre

Study type

Interventional

Funder types

Other

Identifiers

NCT04533945
20-0214

Details and patient eligibility

About

Using the Libre during the TOC with persons with T2D will improve patient glucose monitoring and satisfaction, which can potentially lead to an improvement in glycemic control and hospital utilization. This study aims to assess this with inpatients using insulin.

Full description

Integrating the use of the Libre during the TOC will improve patient glucose monitoring and satisfaction, which can potentially lead to an improvement in glycemic control and hospital utilization. Inpatients admitted to the medical-surgical units would be considered based on the inclusion and exclusion criteria. If the patient qualifies they would be consented to participate in the trial. In addition they would be given a script for refills. Primary outcome is change in HbA1c and secondary outcomes at baseline and 90 days include satisfaction, number of ED/inpatient visits, completion of follow-up appointment, and duration of CGM use.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

* Persons with T2DM * Persons on atleast 3 injections of insulin/day * Persons whose insurance will cover the device

Exclusion criteria

* Persons with adhesive allergy * Pregnant women * Persons with CKD 4/5 or on dialysis

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

FreeStyle Libre Device
Other group
Description:
Inpatients admitted to the medical-surgical units that are eligible for the trial will have the FreeStyle Libre device will be placed by the inpatient diabetes team at the discharge and glucose log will be obtained in 2 weeks followed by Hba1c in 3 months.
Treatment:
Device: FreeStyle Libre

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems